2
Total Mentions
2
Documents
8
Connected Entities
Name reference in documents
EFTA00848760
BIOTECHNOLOGIES, REPORTS 2Q '15 FINANCIAL RESULTS, Avalanche Bio Falls After Scrapping Plans for Ph.2b Study in 2H 2015-08-13 20:35:05.499 GMT By Jeremy R. Cooke (Bloomberg) -- Avalanche Biotechnologies said it won't initiate Phase 2b trial in 2H of 2015 after further analyses of previously reported Phase 2a
EFTA01368503
BIOTECHNOLOGIES, REPORTS 2Q'15 FINANCIAL RESULTS, Avalanche Bio Falls After Scrapping Plans for Ph.2b Study in 2H 2015-08-13 20:35:05.499 GMT By Jeremy R. Cooke (Bloomberg) -- Avalanche Biotechnologies said it won't initiate Phase 2b trial in 2H of 2015 after further analyses of previously reported Phase 2a

Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company
AVA-101
OrganizationOrganization referenced in documents
Avalanche Bio Falls
PersonName reference in documents
Avalanche Biotechnologies, Inc.
OrganizationOrganization referenced in documents
AVA-101 Program
OrganizationOrganization referenced in documents
post-mkt
OrganizationOrganization referenced in documents
Controversial Data
OrganizationOrganization referenced in documents
NH BFW
OrganizationOrganization referenced in documents